Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 1 · 20%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 2 · 40%High 0 · 0%

Recurrence of stroke at the end of · people with acute ischemic stroke

Calcium antagonists showed no clear difference in recurrence of stroke at the end of compared with placebo (moderate certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 0.93 [0.56, 1.54]
9 studies · 2460 participants
Moderate

Recurrence of stroke at the end of · people with acute ischemic stroke

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Low

Recurrence of stroke at the end of · people with acute ischemic stroke

Nimodipine showed no clear difference in recurrence of stroke at the end of compared with placebo (moderate certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 0.98 [0.96, 1.11]
6 studies · 1677 participants
Moderate

Recurrence of stroke at the end of · people with acute ischemic stroke

Flunarizine showed no clear difference in recurrence of stroke at the end of compared with placebo (low certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 0.82 [0.35, 1.97]
2 studies · 764 participants
Low

Recurrence of stroke at the end of · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found